How do the COVID vaccines work? How do we prioritise recipients? What are the major decisions facing policymakers when executing a mass vaccination campaign — and where can science help to advise them?
George Griffin discusses these questions with Toby Wardman of SAPEA. We also discuss how to get jabs to developing countries, the origins of the anti-vax movement, and whether we should be worried about rare blood clots.
Special thanks to Rúben Castro for technical help in producing this episode.
Veera Mitzner is the organiser of the Sustainability Research and Innovation Congress, a major annual event which brings together thousands of researchers, stakeholders and, yes, policymakers. But how do events like this fit into the broader evidence-for-policy landscape?
Greece does not have a long tradition of institutionalised science advisory mechanisms, but after dealing relatively well with Covid, the situation is starting to change. Professor Stella Ladi, an expert on evidence-informed policymaking at home and internationally, talks to Toby Wardman about the past, present and future of science advice in Greece.
The EU climate law created a new institution, the European Scientific Advisory Board on Climate Change, which started work just this year and targets the European Commission, Parliament and Council. Its chair, Professor Ottmar Edenhofer, took time out of his busy schedule to share with us what it’s like setting up a new science advice body and how happy he is with their first significant report.
SAPEA is funded by the European Union. The activities of associated partners Academia Europaea and Cardiff University are funded by UKRI (grant number 10033786).
© SAPEA 2023
